Stimulant induced psychosis

Child and Adolescent Mental Health

Volumn 14, Issue 1, 2009, Pages 20-23

  Shibib, Shatha ^a   Chalhoub, Nevyne ^a  

^a SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ADHD; Psychosis; Stimulants

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE;

ADJUVANT THERAPY; ADOLESCENT; ANOREXIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; AUDITORY HALLUCINATION; CASE REPORT; CONCENTRATION LOSS; CONDUCT DISORDER; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RECHALLENGE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; IRRITABILITY; LOW DRUG DOSE; MALE; MENTAL DISEASE; MOOD DISORDER; PARANOIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RESTLESSNESS; SCHOOL CHILD; SIDE EFFECT; SPEECH DISORDER; VISUAL HALLUCINATION;

EID: 58749105341     PISSN: 1475357X     EISSN: 14753588     Source Type: Journal    
DOI: 10.1111/j.1475-3588.2008.00490.x     Document Type: Article

References (23)

1. AACAP (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 26S-49S.
2. Arnold, L.E., Jensen, P., Hechtman, L. (2000). Do the MTA treatment effects persist? New follow up at 24 months. In: Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 20 Oct, New York, (pp. 65-66).
3. Barkley, R.A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 18, 137-165.
4. Barkley, R.A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guildford Press.
5. Barkley, R.A., McMurray, M.B., Edelbrock, C.S., & Robbins, K. (1990). Side effects of methylphenidate in children with attention hyperactivity disorder: A systemic, placebo controlled evaluation. Pediatrics, 86, 184-192.
6. Bloom, A.S., Russell, L.J., Weisskopf, B., & Blackerby, J.L. (1988). Methylphenidate induced delusional disorder in a child with attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 88-89.
7. Caplan, R., & Tanguay, P.E. (1991). Development of psychotic thinking in children. In: M. Lewis (Ed.), Child and adolescent psychiatry: A comprehensive textbook. (pp. 310-317). Philadelphia: Lippincott, Williams and Wilkins.
8. Cherland, E., & Fitzpatrick, R. (1999). Psychotic side effects of psychostimulants: A 5-year review. Canadian Journal of Psychiatry, 44, 811-813.
9. Gadow, K.D. (1992). Pediatric psychopharmacotherapy: A review of recent research. Journal of Child Psychology and Psychiatry, 33, 153-195.
10. Greenhill, L.L., Halperin, J.M., & Abikoff, H. (1999). Stimulant medications. Journal of the American Academy of Child Adolescent Psychiatry, 38, 503-512.
11. Koehler-Troy, C., Strober, M., & Malenbaum, R. (1986). Methylphenidate induced mania in a prepubertal child. Journal of Clinical Psychiatry, 47, 566-567.
12. Lucas, A.R., & Weiss, M. (1971). Methylphenidate hallucinosis. Journal of the American Medical Association, 217, 1079-1081.
13. MTA Cooperative Group (1999). A 14 month randomised clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
14. Randal, G., & Ross, M.D. (2006). Psychotic and manic like symptoms during stimulant treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry, 163, 1149-1152.
15. Rappley, M.D. (2005). Attention deficit hyperactivity disorder. New England Journal of Medicine, 352, 165-173.
16. Richters, J.E., Arnold, L.E., Jensen, P.S., Abikoff, H., Conners, C.K., Greenhill, L.L., Hechtman, L., Hinshaw, S.P., Pelham, W.E., & Swanson, J.M. (1995). NIMH collaborative multisite multimodal treatment study of children with ADHD: Background and rationale (review). Journal of the American Academy of Child and Adolescent Psychiatry, 34, 987-1000.
17. Rosenfeld, A.A. (1979). Depression and psychotic regression following prolonged methylphenidate use and withdrawal: Case report. American Journal of Psychiatry, 136, 226-228.
18. Schachar, R.J., Tannock, R., Cunningham, C., & Corkum, P.V. (1997). Behavioural, situational, and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 754-763.
19. Spensley, J., & Rockwell, D.A. (1972). Psychosis during methylphenidate abuse. New England Journal of Medicine, 286, 880-881.
20. Weiss, G. (1991). Attention deficit hyperactivity disorder. In: M. Lewis (Ed.), Child and adolescent psychiatry: A comprehensive textbook, (pp. 554-561). New York: Williams and Wilkins.
21. Weiss, G., & Hechtman, L.T. (1993). Medication treatment of ADHD. In: G. Weiss & L.T. Hechtman (Eds.), Hyperactive children grown up (2nd ed.). New York, NY: Guildford Press.
22. Wolraich, M.L., & Doffing, M.A. (2004). Parmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs, 18, 243-250.
23. Young, J. (1981). Methylphenidate induced hallucinosis: Case histories and possible mechanism of action. Journal of Developmental and Behavioural Pediatrics, 2, 35-38.